Article PDF
Author information
Author notes
Michael Osband is director of the Joint Clinical Immunotherapy Program of Boston University School of Medicine (125 Parker Hill Avenue, Boston, MA 02120) and the New England Baptist Hospital, and Chief of the Division of Pediatric Hematology-Oncology of the Department of Pediatrics of Boston University School of Medicine and Boston City Hospital. He is also chief technical officer and executive VP of Cellcor Therapies.
- Michael Osband
Gary Cashon is chairman of the board of directors of Cellcor Therapies, and managing partner of Hillman Medical Ventures. These opinions are the authors' own, and are not necessarily those of Bio/Technology.
- Gary Cashon
Rights and permissions
About this article
Cite this article
Osband, M., Cashon, G. Biocare: Public Policy Issues for an Emerging Industry. Nat Biotechnol 8, 880 (1990). https://doi.org/10.1038/nbt0990-880
Issue Date:
DOI: https://doi.org/10.1038/nbt0990-880